- $1.20bn
- $2.53bn
- $1.41bn
- 67
- 27
- 84
- 62
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 7.07 | ||
| PEG Ratio (f) | 0.12 | ||
| EPS Growth (f) | 142% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 6.14 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 23.49 | ||
| Price to Sales | 0.85 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -30.46% | ||
| Return on Equity | -104.11% | ||
| Operating Margin | -38.08% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 1,216.1 | 1,391.5 | 1,668.3 | 1,692.1 | 1,406.4 | 1,356 | 1,422 | 1.7% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -2.66 | +0.43 | +22.88 | -42.38 | -77.53 | +478.1 | +17.2 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Ingevity Corporation is engaged in developing, marketing, and bringing to market solutions that are renewably sourced. The Company operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies. Performance Materials segment engineers, manufactures, and sells hardwood-based, chemically activated carbon products, which are produced through a technical and specialized process primarily for use in gasoline vapor emission control systems in cars, trucks, motorcycles, and boats. Performance Chemicals segment is comprised of two product lines: road technologies and industrial specialties. Its products are utilized in pavement construction, preservation, reconstruction and recycling, agrochemical dispersants, paper chemicals and other diverse industrial uses. Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers for use in coatings, resins, elastomers, adhesives, bioplastics, and medical devices.
Directors
- Jean Blackwell NEC (67)
- John Fortson PRE (53)
- Mary Hall CFO (64)
- Stacy Cozad EVP (50)
- Michael Smith EVP (60)
- S. Edward Woodcock EVP (55)
- Ryan Fisher GCN
- Luis Fernandez-Moreno IND (57)
- J. Michael Fitzpatrick IND (74)
- Diane Gulyas IND (64)
- Karen Narwold IND (61)
- Daniel Sansone IND (68)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- March 27th, 2015
- Public Since
- May 2nd, 2016
- No. of Shareholders
- 4,200
- No. of Employees
- 1,600
- Sector
- Chemicals
- Industry
- Basic Materials
- Exchange
New York Stock Exchange- Shares in Issue
- 36,439,270
- Address
- 4920 O'HEAR AVENUE, SUITE 400, NORTH CHARLESTON, 29405
- Web
- https://www.ingevity.com/
- Phone
- +1 8437402300
- Contact
- John Nypaver
- Auditors
- PricewaterhouseCoopers LLP
Upcoming Events for NGVT
Q1 2025 Ingevity Corp Earnings Release
Q1 2025 Ingevity Corp Earnings Call
Q2 2025 Ingevity Corp Earnings Release
Q3 2025 Ingevity Corp Earnings Release
Similar to NGVT
AdvanSix
New York Stock Exchange
Air Products and Chemicals
New York Stock Exchange
Albemarle
New York Stock Exchange
Albemarle
New York Stock Exchange
American Vanguard
New York Stock Exchange
FAQ
What is the Ingevity share price?
As of Today at 21:19 UTC, shares in Ingevity are trading at $32.88. This share price information is delayed by 15 minutes.
How has the Ingevity share price performed this year?
Shares in Ingevity last closed at $32.88 and the price had moved by -31.31% over the past 365 days. In terms of relative price strength the Ingevity share price has underperformed the S&P500 Index by -36.6% over the past year.
What are the analyst and broker recommendations for Ingevity?
The overall consensus recommendation for Ingevity is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Ingevity dividend yield?
Ingevity does not currently pay a dividend.
Does Ingevity pay a dividend?
Ingevity does not currently pay a dividend.
When does Ingevity next pay dividends?
Ingevity does not currently pay a dividend.
How do I buy Ingevity shares?
To buy shares in Ingevity you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Ingevity?
As of the previous close price of $32.88, shares in Ingevity had a market capitalisation of $1.20bn.
Where are Ingevity shares listed?
Here are the trading details for Ingevity:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: NGVT
What kind of share is Ingevity?
Based on an overall assessment of its quality, value and momentum Ingevity is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Ingevity share price forecast for 2025?
The analyst consensus target price for shares in Ingevity is $49.75. That is 51.31% above the last closing price of $32.88.
Analysts covering Ingevity currently have a consensus Earnings Per Share (EPS) forecast of $4.41 for the next financial year.
Find out moreWhat is the trend in the Ingevity share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Ingevity. Over the past six months, its share price has outperformed the S&P500 Index by +2.99%.
As of the last closing price of $32.88, shares in Ingevity were trading -19.88% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Ingevity PE Ratio?
The Ingevity PE ratio based on its reported earnings over the past 12 months is 7.07. The shares last closed at $32.88.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Ingevity?
Ingevity's management team is headed by:
- Jean Blackwell - NEC
- John Fortson - PRE
- Mary Hall - CFO
- Stacy Cozad - EVP
- Michael Smith - EVP
- S. Edward Woodcock - EVP
- Ryan Fisher - GCN
- Luis Fernandez-Moreno - IND
- J. Michael Fitzpatrick - IND
- Diane Gulyas - IND
- Karen Narwold - IND
- Daniel Sansone - IND